Current:Home > Contact-usFDA approves gene-editing treatment for sickle cell disease-LoTradeCoin
FDA approves gene-editing treatment for sickle cell disease
View Date:2024-12-23 15:37:41
The U.S. Food and Drug Administration on Friday approved a landmark gene-editing treatment for sickle cell disease, a painful condition that affects approximately 100,000 people in the United States, predominantly people of color. The innovative therapy promises to repair the gene responsible for the disease.
The breakthrough offers a beacon of hope for Johnny Lubin, a 15-year-old from Connecticut who has lived with the debilitating effects of the disease. He inherited the sickle cell gene from both of his parents and has experienced severe pain and health complications since infancy.
Red blood cells, which are normally donut-shaped, bend into inflexible sickle shapes, causing them to pile up inside blood vessels and prevent the normal delivery of oxygen in the body. Complications include bone deterioration, strokes and organ failure.
Doctors told Lubin he would not live past 40.
"I was starting to get a little bit scared. Like I actually did want to live past 40," he said.
For more than a decade, Lubin was in and out of the hospital. He said he would count how many times he had been in each hospital room and at one point he realized he had been in every room on the floor.
Johnny's parents, Fabienne and J.R. Lubin, were desperate for a solution when they learned about a cutting-edge clinical trial involving gene editing, a process not requiring a donor.
First, stem cells were removed from Lubin's bone marrow and he was given chemotherapy to help wipe out the abnormal cells.
Then, in a laboratory, the editing technology called CRISPR was used to increase the amount of a protective form of hemoglobin, a protein that picks up oxygen from lungs and delivers it throughout the body — that protective form usually diminishes after birth. The cells were then infused back into Lubin's bloodstream.
Dr. Monica Bhatia, who is Johnny's doctor and the chief of pediatric stem cell transplantation at NewYork-Presbyterian/Columbia University Irving Medical Center, said by editing the cell, you're reprogramming cells to produce fetal hemoglobin.
"It's been widely known that fetal hemoglobin is somewhat protective and those who have higher levels of fetal hemoglobin tend to have less severe symptoms of sickle cell disease," she said.
"You're changing somebody's DNA. So obviously you wanna make sure that the corrections you're making are, are the ones you want," said Bhatia.
After a challenging five weeks in the hospital and a six-month absence from school, Lubin has drastically improved health and prospects for a longer life.
"I thought that was pretty cool how I have like new cells and I honestly hoped, you know, I could get, you know, some super powers from it, you know, maybe become a superhero, you know, like genetically engineered," Lubin said.
The treatment, called Casgevy, was developed by the Boston-based Vertex Pharmaceuticals and CRISPR Therapeutics.
Patients will have to be followed long-term before the experts call this a cure. Gene editing is expected to cost several million dollars per patient and may not be appropriate for everyone who has sickle cell disease. It would also not prevent the gene from being passed down to future generations.
Jon LaPookDr. Jonathan LaPook is the chief medical correspondent for CBS News.
TwitterveryGood! (782)
Related
- Kyle Richards Shares an Amazing Bottega Dupe From Amazon Along With Her Favorite Fall Trends
- Beyond 'Margaritaville': Jimmy Buffett was great storyteller who touched me with his songs
- Minnesota political reporter Gene Lahammer dies at 90
- Domestic violence charges dropped against Arizona Coyotes minority owner Andrew Barroway
- Kevin Costner Shares His Honest Reaction to John Dutton's Controversial Fate on Yellowstone
- Metal debris strikes car windshield on Maine highway and comes within inches of motorist’s face
- Authorities expand search area for killer who escaped Pennsylvania prison after latest sighting
- Marion Cotillard Is All Of Us Reacting to Those Joe Jonas and Sophie Turner Divorce Rumors
- Japan to resume V-22 flights after inquiry finds pilot error caused accident
- 2 adults, 2 children and dog found dead in Seattle house after fire and reported shooting; 11-year-old girl escapes
Ranking
- Anti-abortion advocates press Trump for more restrictions as abortion pill sales spike
- Jimmy Buffett died from Merkel cell skin cancer. What to know about the rare skin condition.
- Alabama man convicted of sexually torturing, robbing victims he met online
- Mariners' Julio Rodríguez makes MLB home run, stolen base history
- Rita Ora pays tribute to Liam Payne at MTV Europe Music Awards: 'He brought so much joy'
- Former Proud Boys leader Enrique Tarrio faces sentencing in the Jan. 6 Capitol attack
- Georgia can resume enforcing ban on hormone replacement therapy for transgender youth, judge says
- Gary Wright, 'Dream Weaver' and 'Love is Alive' singer, dies at 80 after health battle: Reports
Recommendation
-
Mike Tyson concedes the role of villain to young foe in 58-year-old’s fight with Jake Paul
-
Maya Hawke Roasts Dad Ethan Hawke for Trying to Flirt With Rihanna
-
Philadelphia Police Commissioner Danielle Outlaw is resigning, mayor says
-
Novak Djokovic beats Taylor Fritz at the US Open to reach his record 47th Grand Slam semifinal
-
Kyle Richards Shares an Amazing Bottega Dupe From Amazon Along With Her Favorite Fall Trends
-
Spanish soccer federation fires women’s national team coach Jorge Vilda amid Rubiales controversy
-
Tennessee zoo reveals name of rare giraffe without spots – Kipekee. Here's what it means.
-
Amid dispute with Spectrum, Disney urges cable viewers to switch to its Hulu+ service